Suchergebnisse - "Fajgenbaum, David C."

PubPharm (116)

111

Idiopathic multicentric Castleman's disease : a systematic literature review

enthalten in: The Lancet. Haematology | 2016

von Liu, A. | Nabel, C. | Finkelman, B. | +7

CommentIn: Lancet Haematol. 2016 Apr;3(4):e150-2. - PMID 27063967

112

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease

enthalten in: American journal of hematology | 2016

von Iwaki, N. | Fajgenbaum, D. | Nabel, C. | +19

113

Siltuximab : a targeted therapy for idiopathic multicentric Castleman disease

enthalten in: Immunotherapy | 2016

von Fajgenbaum, D. | Kurzrock, R.

114

Taking Control of Castleman Disease : Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research

enthalten in: The Yale journal of biology and medicine | 2015

von Newman, S. | Jayanthan, R. | Mitchell, G. | +8

115

HHV-8-negative, idiopathic multicentric Castleman disease : novel insights into biology, pathogenesis, and therapy

enthalten in: Blood | 2014

von Fajgenbaum, D. | van Rhee, F. | Nabel, C.

116

Eruptive cherry hemangiomatosis associated with multicentric Castleman disease : a case report and diagnostic clue

enthalten in: JAMA dermatology | 2013

von Fajgenbaum, D. | Fajgenbaum, D. | Rosenbach, M. | +3

ErratumIn: JAMA Dermatol. 2014 Apr;150(4):460 Fajgenbaum, David [corrected to Fajgenbaum, David C]

[1]
« Vorheriger
2
3
4
5
6
7
8
9
10
11
12